{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:28:11Z","timestamp":1768278491918,"version":"3.49.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1995,4]]},"DOI":"10.1212\/wnl.45.4.829","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:15:41Z","timestamp":1336914941000},"page":"829-830","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":46,"title":["Ginseng-associated cerebral arteritis"],"prefix":"10.1212","volume":"45","author":[{"given":"Shan-Jin","family":"Ryu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Yi","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"1","volume":"241","year":"1979","unstructured":"Siegel RK. Ginseng abuse syndrome: problems with the panacea. JAMA 1979;241:1614-1615.","journal-title":"JAMA"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.1.1"},{"key":"e_1_3_1_4_2","first-page":"5","volume":"40","year":"1983","unstructured":"Harrington H, Heller HA, Dawson D, Caplan L, Rumbaugh C. Intracerebral hemorrhage and oral amphetamine. Arch Neurol 1983;40:503-507.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.1.3"},{"key":"e_1_3_1_6_2","first-page":"3","volume":"17","year":"1981","unstructured":"Owen RT. Ginseng: a pharmacological profile. Drugs Today 1981;17:343-351.","journal-title":"Drugs Today"},{"key":"e_1_3_1_7_2","first-page":"7","volume":"35","year":"1984","unstructured":"Martinez B, Staba EJ. The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats. Jpn J Pharmacol 1984;35:79-85.","journal-title":"Jpn J Pharmacol"},{"key":"e_1_3_1_8_2","first-page":"5","volume":"237","year":"1986","unstructured":"Baldwin CA, Anderson LA, Phillipson JD. What pharmacists should know about ginseng. Pharm J 1986;237:583-586.","journal-title":"Pharm J"},{"key":"e_1_3_1_9_2","first-page":"1","volume":"232","year":"1984","unstructured":"Phillipson JD, Anderson LA. Ginseng-quality, safety and efficacy? Pharm J 1984;232:161-165.","journal-title":"Ginseng-quality, safety and efficacy? Pharm J"},{"key":"e_1_3_1_10_2","first-page":"2","volume":"328","year":"1993","unstructured":"Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_11_2","first-page":"5","volume":"2","year":"1985","unstructured":"Barna P. The case of ginseng. Lancet 1985;2:548.","journal-title":"Lancet"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.45.4.829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:59:11Z","timestamp":1711641551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.45.4.829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["10.1212\/WNL.45.4.829"],"URL":"https:\/\/doi.org\/10.1212\/wnl.45.4.829","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}